SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001571049-17-003521
Filing Date
2017-04-12
Accepted
2017-04-12 16:35:57
Documents
6
Effectiveness Date
2017-04-12

Document Format Files

Seq Description Document Type Size
1 DEFA14A t1700099x2_def14a.htm DEFA14A 24783
2 GRAPHIC t1700099_pg1def14a.jpg GRAPHIC 183113
3 GRAPHIC t1700099_pg2def14a.jpg GRAPHIC 313411
4 GRAPHIC t1700099_pg3def14a.jpg GRAPHIC 204864
5 GRAPHIC t1700099_pg4def14a.jpg GRAPHIC 133272
6 GRAPHIC t1700099_pg5def14a.jpg GRAPHIC 9945
  Complete submission text file 0001571049-17-003521.txt   1173210
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-50626 | Film No.: 17758331
SIC: 2834 Pharmaceutical Preparations